Beth Johnson

Beth Johnson has extensive work experience in various roles within the medical and pharmaceutical industry. Beth currently serves as the Director of Commercial Development at MindRhythm, Inc. Prior to this, they were the Owner-Operator of LYGRR, where they provided guidance to EPA and FDA regulated companies on market dynamics, product positioning, and commercial strategy.

Before that, Beth worked as the Director of Strategic Development at Ornim Medical, where they played a crucial role in facilitating communication and strategy development among cross-functional teams. Beth also previously worked as a Territory Manager in the Medical Dermatology Division at Merz North America, where they successfully turned around a 2-state territory and later expanded their responsibilities to a 5-state territory.

Beth's experience also includes working as a Territory Manager at ZOLL Medical Corporation, where they focused on elevating sales of wearable defibrillator products. Prior to that, they worked as a Sales Representative and Sales Specialist at Daiichi Sankyo, driving sales of cardiovascular products in a strictly managed primary care environment. Beth also worked as a Senior Sales Representative at GSK, where they revitalized sales of cardiovascular products in an underperforming territory.

Throughout their career, Beth has consistently demonstrated their ability to strategically drive sales, establish strong relationships with stakeholders, and effectively communicate and execute cross-functional strategies.

Beth Johnson's education history includes attending Yale University from 1998 to 2001, where they studied Opera Performance. Prior to that, they obtained a Bachelor's Degree from Quinnipiac University, graduating in 2001. Their major was Marketing & Communications, with a minor in English. Furthermore, Beth's educational background includes completing the International Baccalaureate program, although specific dates are not provided.

In addition to their formal education, Beth Johnson has obtained several certifications. Beth is a Certified Clinical Research Coordinator (CCRC), obtained in September 2022 from the U.S. Department of Health and Human Services (HHS). Beth also holds a certification as a HIPAA Professional (HIPAAP) from the same institution, obtained in September 2022. In 2015, Beth obtained the Reptrax Cedentialed certification. Their additional certifications include Business Analytics from Babson University, as well as a Graduate accreditation from the American Society for Hypertension Accreditation Program. However, the specific dates of when they obtained these certifications are not provided.